DISCLAIMER: The White Paper on Species/Stock/Strain in Endocrine Disruptor Assays was prepared in response to an Interim Recommendation from the Endocrine Disruptor Methods Validation Subcommittee (EDMVS) and in support of further discussion on this topic by the EDMVS. It does not represent Agency findings, determinations, or policy.
The White Paper was prepared by a contractor to the EPA and represents the contractor's best effort to review and evaluate the scientific literature on species, stock, and strain considerations that affect endpoints under consideration for inclusion in the Endocrine Disruptor Screening Program. As part of the preparation of the White Paper, the contractor submitted a draft for review by an external reviewer. The reviewer requested that his comments be posted along with the White Paper. Although this is an unusual procedure, the Agency agreed to do so. The Agency regards both the White Paper that responds to an EDMVS request and the Reviewer's Appendix as contractor products, not as Agency products that establish an Agency position.
The following links provide access to a White Paper on Species/Stock/Strain in Endocrine Disruptor Assays.
- White Paper on Species/Strain/Stock in Endocrine Disruptor Assays [PDF file, 97pp., 564KB, About PDF]
- Reviewer's Appendix to the White Paper on Species/Stock/Strain in Endocrine Disruptor Assays [PDF file, 97pp., 542KB, About PDF]
You will need the free Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more. If you need help accessing these PDF documents, please contact William Wooge at 202-564-8476 or email@example.com for assistance.